|This Slide: #58 of 100|
Slide #58. Quintiles — Novella Clinical
To stay ahead of the diverse and evolving needs of its global customer base, Quintiles today announced it has signed an agreement to acquire Novella Clinical (Novella), a full-service clinical research organization (CRO) focused primarily on emerging oncology customers as well as those in the medical device and diagnostics sectors.
Quintiles IMS Holdings is an integrated information and technology-enabled healthcare service provider. Co. has three operating segments: Commercial Solutions, Research & Development Solutions and Integrated Engagement Services. Co.'s principal Commercial Solutions offerings include: national information offerings and sub-national information offerings. Co.'s principal Research & Development Solutions offerings include: project management and clinical monitoring, clinical trial support services, and Q2 Solutions. Co.'s principal Integrated Engagement Services offerings include: health care provider engagement services, patient engagement services, and medical affairs services.
Open the Q Page at The Online Investor »
Buy (2.85 out of 4)
(ranked higher than approx. 100% of all stocks covered)
Based on Zacks ABR data;
powered by Xignite